Category: HypertensionSyndicate content

Renal denervation: Ablative Solutions wins CE Mark for chemical ablation catheter

May 13, 2015 by Fink Densford

Ablative Solutions wins CE Mark approval in the European Union for its Peregrine infusion ablation catheter for treating uncontrolled hypertension.

Hypertension: Ablative Solutions wins CE Mark for infusion ablation catheter

Ablative Solutions said it received CE Mark approval for its Peregrine infusion ablation catheter for treating uncontrolled hypertension. The company began testing Peregrine last year in Poland.

Renal denervation: Boston Scientific launches new Vessix trial

April 17, 2015 by Brad Perriello

Boston Scientific launches a clinical trial of its Vessix renal denervation device in treating hypertension, aiming to separate its effects from drug therapy for high blood pressure.

Renal denervation: Boston Scientific launches new Vessix trial

ReCor Medical raises $15M for ultrasound RDN

April 13, 2015 by Mark Hollmer

ReCor Medical raises a $15 million Series D financing for a planned U.S. study of its ultrasound renal denervation device.

ReCor Medical raises $15M for ultrasound RDN

A Japanese healthcare conglomerate is the lead investor ReCor Medical's $15 million Series D round ReCor plans to use to back a U.S. clinical trial of its ultrasound renal denervation device.

Medtronic takes another crack at renal denervation

April 1, 2015 by Brad Perriello

Medtronic launches a new clinical trial examining renal denervation as a treatment for hypertension, aiming to settle the 'confounding factors' that led to the failure of its Symplicity-3 trial.

Medtronic takes another crack at renal denervation

Renal Denervation: Medtronic taking another shot at drug-resistant hypertension

February 20, 2015 by Mark Hollmer

Medtronic is taking another shot at renal denervation to treat drug-resistant hypertension, a year after a pivotal trial for its key product in the space failed to meet its efficacy endpoint.

Renal denervation: Analysis highlights 'confounding' factors in Medtronic's Symplicity-3 trial

Hypertension: Stealthy Verve Medical raises $2m for RDN device

February 3, 2015 by Mark Hollmer

Verve Medical raises just less than $2 million in an equity offering for its renal denervation device.

Hypertension: Stealthy Verve Medical raises $2m for RDN device

Stealthy renal denervation startup Verve Medical raised close to $2 million, according to a regulatory filing, with funding likely slated to help support clinical trials.

UPDATE: Rox Medical's Coupler hypertension stent fares well in pivotal trial

January 28, 2015 by Mark Hollmer

Rox Medical's stent-like Coupler implant, designed to treat resistant hypertension, fares well in a pivotal trial as the company gears up for a run at an investigational device exemption from the FDA.